Kurt Klemm

Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance

Volker Gekeler, R. Boer, Florian Überall et al. · British Journal of Cancer · 1996 · 119 citations · Full text

Medicine, Oncology, Pharmacology +12

Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung

Tilman Voss, Klaus Schäfer, Per F. Nielsen et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1992 · 73 citations

Life Sciences, Biochemistry, Molecular Biology +9

(H+, K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate

Bernhard Kohl, Ernst Sturm, Joerg Senn‐Bilfinger et al. · Journal of Medicinal Chemistry · 1992 · 68 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiols

Joerg Senn‐Bilfinger, U. KRUEGER, Ernst Sturm et al. · The Journal of Organic Chemistry · 1987 · 48 citations

Life Sciences, Biochemistry, Chemistry +8

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 1. Their reaction with thiols under acidic conditions. Disulfide containing 2-pyridiniobenzimidazolides as mimics for the inhibited enzyme

Ernst Sturm, U. KRUEGER, Joerg Senn‐Bilfinger et al. · The Journal of Organic Chemistry · 1987 · 44 citations

Life Sciences, Biochemistry, Pharmacology +13